结扎与即刻血运重建治疗静脉吸毒继发股动脉假性动脉瘤的系统评价与Meta分析
该系统评价与Meta分析纳入39项队列研究共1217例静脉吸毒相关股动脉假性动脉瘤手术结局,比较结扎清创与切除血运重建。两组30天死亡率、截肢率和慢性肢体威胁性缺血无显著差异,但血运重建组再干预率和再出血率更高。
要点
- 结扎清创与切除血运重建的截肢率和慢性肢体威胁性缺血无显著差异
- 血运重建组再干预率显著高于结扎清创组
- 血运重建组再出血率在数值上更高但差异未达统计学显著
核心结论
- 静脉吸毒相关股动脉假性动脉瘤行结扎清创或切除血运重建,死亡率、截肢率和慢性肢体威胁性缺血无显著差异。
- 血运重建患者再干预率显著更高,再出血率在数值上更高。
研究设计与样本
- 遵循PRISMA指南的系统评价与Meta分析。
- 纳入39项队列研究,共1217例股动脉假性动脉瘤手术结局。
- 993例(81.6%)行结扎清创,224例(18.4%)行切除血运重建。
主要发现
- 30天死亡率结扎清创组0.8%(n=8),切除血运重建组1.3%(n=3),仅1项研究同时报告两组死亡率。
- 截肢率结扎清创组8.89% vs 血运重建组8.03%,OR 0.74(95%CI 0.35-1.56),P=0.42,纳入11项研究。
- 慢性肢体威胁性缺血发生率结扎清创组21.5% vs 血运重建组12.4%,OR 1.24(95%CI 0.35-4.38),P=0.74,纳入9项研究。
- 再干预率结扎清创组24.7% vs 血运重建组10.6%,OR 0.31(95%CI 0.16-0.62),P=0.0009,纳入13项研究。
- 再出血率结扎清创组7.1% vs 血运重建组1.6%,OR 0.61(95%CI 0.16-2.38),P=0.48,纳入5项研究。
临床怎么用
- 对于静脉吸毒相关股动脉假性动脉瘤,结扎清创可作为可选术式,其截肢率和慢性肢体威胁性缺血风险与血运重建相当。
- 若选择切除血运重建,需警惕更高的再干预率和再出血风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Femoral artery pseudoaneurysms (FA-PSAs) remain a common vascular aneurysmal pathology associated with intravascular drug use (IVDU). To date no internationally agreed consensus regarding optimal surgical management of FA-PSAs exists. The aim of this systematic review and meta-analysis was to determine the optimal surgical treatment of FA-PSAs associated with IVDU. METHODS: A systematic search was undertaken following PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines identifying original studies reporting outcomes of ligation-debridement and/or excision-revascularization of FA-PSAs secondary to IVDU. Outcomes of interest were 30-day mortality, incidence of amputation at 12 months, chronic limb threatening ischemia (CLTI) at any follow-up appointment, reintervention, and bleeding. RESULTS: A total of 39 cohort studies describing 1,217 FA-PSA operative outcomes met inclusion criteria, 993 (81.6%) treated by ligation-debridement and 224 (18.4%) by excision-revascularization. The incidence of 30-day mortality was 0.8% (n = 8) and 1.3% (n = 3) in the ligation-debridement and excision-revascularization groups, respectively, with only one study reporting mortality in both groups. This meta-analysis found no difference in amputation (8.89% vs. 8.03%, odds ratio (OR) 0.74 95% confidence interval (CI) 0.35-1.56, P = 0.42, 11 studies) or CLTI (21.5% vs. 12.4%, OR 1.24 95% CI 0.35-4.38, P = 0.74, 9 studies) after ligation and debridement compared with excision and revascularization. There was a higher incidence of reintervention (24.7% vs. 10.6%, OR 0.31 [95% CI 0.16, 0.62], P = 0.0009, 13 studies) and rebleeding (7.1% vs. 1.6%, OR 0.61 [95% CI 0.16, 2.38], P = 0.48, 5 studies) after excision and revascularization compared with ligation alone. CONCLUSIONS: For treatments of IVDU-related FA-PSAs, this study suggests no significant difference in association of mortality, incidence of amputation, or CLTI with ligation-debridement or excision-revascularization, but a significantly higher reintervention rate and greater rebleeding rate for revascularized patients.
引用
- Singh AA, Ashcroft J, Stather PW, et al. Ligation Alone Versus Immediate Revascularization for Femoral Artery Pseudoaneurysms Secondary to Intravascular Drug Use: A Systematic Review and Meta-Analysis. Ann Vasc Surg. 2020. PMID: 33383134. doi:10.1016/j.avsg.2020.11.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。